Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Frontiers in Physiology
|
March 11, 2021
Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice
Dániel Kucsera, Viktória E Tóth, Dorottya Gergő, et al.
International Journal of Molecular Sciences
|
September 16, 2020
Anti-PD-1 Therapy Does Not Influence Hearing Ability in the Most Sensitive Frequency Range, but Mitigates Outer Hair Cell Loss in the Basal Cochlear Region
Judit Szepesy, Gabriella Miklós, János Farkas, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
Zsófia Onódi, Petra Lujza Szabó, Dániel Kucsera, et al.
Basic Research in Cardiology
|
November 8, 2024
Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice
Nabil V Sayour, Dániel Kucsera, Ayham R Alhaddad, et al.
Scientific Reports
|
January 7, 2023
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
Dániel Kucsera, Viktória E Tóth, Nabil V Sayour, et al.
ESC Heart Failure
|
September 7, 2024
Comparison of mouse models of heart failure with reduced ejection fraction
Nabil V Sayour, Tamás G Gergely, Barnabás Váradi, et al.
Geroscience
|
April 17, 2024
NASH triggers cardiometabolic HFpEF in aging mice
Dániel Kucsera, Mihály Ruppert, Nabil V Sayour, et al.
Cardiovascular Research
|
June 12, 2021
AIM2-driven inflammasome activation in heart failure
Zsófia Onódi, Mihály Ruppert, Dániel Kucsera, et al.
British Journal of Pharmacology
|
November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment
Tamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Frontiers in Physiology
|
March 11, 2021
Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice
Dániel Kucsera, Viktória E Tóth, Dorottya Gergő, et al.
International Journal of Molecular Sciences
|
September 16, 2020
Anti-PD-1 Therapy Does Not Influence Hearing Ability in the Most Sensitive Frequency Range, but Mitigates Outer Hair Cell Loss in the Basal Cochlear Region
Judit Szepesy, Gabriella Miklós, János Farkas, et al.
International Journal of Molecular Sciences
|
May 27, 2023
Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
Zsófia Onódi, Petra Lujza Szabó, Dániel Kucsera, et al.
Basic Research in Cardiology
|
November 8, 2024
Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice
Nabil V Sayour, Dániel Kucsera, Ayham R Alhaddad, et al.
Scientific Reports
|
January 7, 2023
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
Dániel Kucsera, Viktória E Tóth, Nabil V Sayour, et al.
ESC Heart Failure
|
September 7, 2024
Comparison of mouse models of heart failure with reduced ejection fraction
Nabil V Sayour, Tamás G Gergely, Barnabás Váradi, et al.
Geroscience
|
April 17, 2024
NASH triggers cardiometabolic HFpEF in aging mice
Dániel Kucsera, Mihály Ruppert, Nabil V Sayour, et al.
Cardiovascular Research
|
June 12, 2021
AIM2-driven inflammasome activation in heart failure
Zsófia Onódi, Mihály Ruppert, Dániel Kucsera, et al.
British Journal of Pharmacology
|
November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment
Tamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
Page
of 1